Upregulation of nerve growth factor in central amygdala increases sensitivity to opioid reward

Neuropsychopharmacology

Volumn 37, Issue 13, 2012, Pages 2780-2788

  Bie, Bihua ^a   Wang, Yan ^a   Cai, You Qing ^a   Zhang, Zhi ^a   Hou, Yuan Yuan ^a   Pan, Zhizhong Z ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

addiction; delta opioid receptor; drug sensitization; epigenetic modulation; nerve growth factor; opioid reward

Indexed keywords

DELTA OPIATE RECEPTOR; HISTONE H4; MORPHINE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; TRICHOSTATIN A;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONDITIONING; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; ENZYME INHIBITION; EPIGENETICS; GENE EXPRESSION REGULATION; HISTONE ACETYLATION; MALE; NONHUMAN; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; RECEPTOR BLOCKING; REINFORCEMENT; REWARD; REWARD SENSITIZATION; SIGNAL TRANSDUCTION; SYNAPTOSOME; UPREGULATION;

AMYGDALA; ANALGESICS, OPIOID; ANIMALS; MALE; MORPHINE; NERVE GROWTH FACTOR; RATS; RATS, WISTAR; REWARD; UP-REGULATION;

EID: 84869086333     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.144     Document Type: Article

References (50)

1. Baxter MG, Murray EA (2002). The amygdala and reward. Nat Rev Neurosci 3: 563-573.
2. Bie B, Zhang Z, Cai YQ, Zhu W, Zhang Y, Dai J et al (2010). Nerve growth factor-regulated emergence of functional delta-opioid receptors. J Neurosci 30: 5617-5628.
3. Bie B, Zhu W, Pan ZZ (2009a). Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala. Neuroscience 160: 348-358.
4. Bie B, Zhu W, Pan ZZ (2009b). Rewarding morphine-induced synaptic function of delta-opioid receptors on central glutamate synapses. J Pharm Exp Therap 329: 290-296.
5. Cahill CM, Holdridge SV, Morinville A (2007). Trafficking of deltaopioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28: 23-31.
6. Carlezon Jr WA, Nestler EJ (2002). Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 25: 610-615.
7. Chao MV, Bothwell M (2002). Neurotrophins: to cleave or not to cleave. Neuron 33: 9-12.
8. Chefer VI, Shippenberg TS (2009). Augmentation of morphineinduced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice. Neuropsychopharmacology 34: 887-898.
9. Commons KG (2003). Translocation of presynaptic delta opioid receptors in the ventrolateral periaqueductal gray after swim stress. J Comp Neurol 464: 197-207.
10. Contet C, Kieffer BL, Befort K (2004). Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 14: 370-378.
11. Cornish JL, Lontos JM, Clemens KJ, McGregor IS (2005). Cocaine and heroin ('speedball') self-administration: the involvement of nucleus accumbens dopamine and mu-opiate, but not deltaopiate receptors. Psychopharmacology (Berl) 180: 21-32.
12. David V, Matifas A, Gavello-Baudy S, Decorte L, Kieffer BL, Cazala P (2008). Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward. Neuropsychopharmacology 33: 1746-1759.
13. Do Carmo GP, Mello NK, Rice KC, Folk JE, Negus SS (2006). Effects of the selective delta opioid agonist SNC80 on cocaineand food-maintained responding in rhesus monkeys. Eur J Pharmacol 547: 92-100.
14. Dulac C (2010). Brain function and chromatin plasticity. Nature 465: 728-735.
15. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA et al (1999). Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401: 188-193.
16. Gottfried JA, O'Doherty J, Dolan RJ (2003). Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science 301: 1104-1107.
17. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW (2007). Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 10: 1029-1037.
18. Hack SP, Bagley EE, Chieng BC, Christie MJ (2005). Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci 25: 3192-3198.
19. Heberlein A, Muschler M, Frieling H, Behr M, Eberlein C, Wilhelm J et al (2011). Epigenetic down regulation of nerve growth factor during alcohol withdrawal. Addic Biol, e-pub ahead of print 11 March 2011, PMID 21392176.
20. Hyman SE, Malenka RC, Nestler EJ (2006). Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29: 565-598.
21. Jenuwein T, Allis CD (2001). Translating the histone code. Science 293: 1074-1080.
22. Jones S, Bonci A (2005). Synaptic plasticity and drug addiction. Curr Opin Pharmacol 5: 20-25.
23. Kenny PJ, Chartoff E, Roberto M, Carlezon Jr WA, Markou A (2009). NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology 34: 266-281.
24. Koob GF (2008). A role for brain stress systems in addiction. Neuron 59: 11-34.
25. Koob GF, Kenneth Lloyd G, Mason BJ (2009). Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discov 8: 500-515.
26. Kouzarides T (2007). Chromatin modifications and their function. Cell 128: 693-705.
27. Kurdistani SK, Tavazoie S, Grunstein M (2004). Mapping global histone acetylation patterns to gene expression. Cell 117: 721-733.
28. Le Merrer J, Becker JA, Befort K, Kieffer BL (2009). Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
29. Lu H, Cheng PL, Lim BK, Khoshnevisrad N, Poo MM (2010). Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition. Neuron 67: 821-833.
30. Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y (2004). A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24: 1604-1611.
31. Luscher C, Malenka RC (2011). Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69: 650-663.
32. Ma J, Zhang Y, Kalyuzhny AE, Pan ZZ (2006). Emergence of functional {delta}-opioid receptors induced by chronic morphine. Mol Pharmacol 69: 1137-1145.
33. MacDonald JL, Roskams AJ (2009). Epigenetic regulation of nervous system development by DNA methylation and histone deacetylation. Prog Neurobiol 88: 170-183.
34. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383: 819-823.
35. Pan ZZ (1998). mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19: 94-98.
36. Poo MM (2001). Neurotrophins as synaptic modulators. Nat Rev Neurosci 2: 24-32.
37. Robison AJ, Nestler EJ (2011). Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12: 623-637.
38. Russo SJ, Dietz DM, Dumitriu D, Morrison JH, Malenka RC, Nestler EJ (2010). The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci 33: 267-276.
39. Schmidt BL, Tambeli CH, Barletta J, Luo L, Green P, Levine JD et al (2002). Altered nucleus accumbens circuitry mediates paininduced antinociception in morphine-tolerant rats. J Neurosci 22: 6773-6780.
40. Schroeder FA, Penta KL, Matevossian A, Jones SR, Konradi C, Tapper AR et al (2008). Drug-induced activation of dopamine D(1) receptor signaling and inhibition of class I/II histone deacetylase induce chromatin remodeling in reward circuitry and modulate cocaine-related behaviors. Neuropsychopharmacology 33: 2981-2992.
41. Shippenberg TS, Chefer VI, Thompson AC (2009). Deltaopioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biol Psychiatry 65: 169-174.
42. Siggins GR, Martin G, Roberto M, Nie Z, Madamba S, De Lecea L (2003). Glutamatergic transmission in opiate and alcohol dependence. Ann NY Acad Sci 1003: 196-211.
43. Simmons D, Self DW (2009). Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior. Neuropsychopharmacology 34: 1946-1957.
44. Strahl BD, Allis CD (2000). The language of covalent histone modifications. Nature 403: 41-45.
45. Tzschentke TM (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addic Biol 12: 227-462.
46. Waldhoer M, Bartlett SE, Whistler JL (2004). Opioid receptors. Annu Rev Biochem 73: 953-990.
47. Wang Y, Krishnan HR, Ghezzi A, Yin JC, Atkinson NS (2007). Druginduced epigenetic changes produce drug tolerance. PLoS Biol 5: e265.
48. Ward SJ, Roberts DC (2007). Microinjection of the delta-opioid receptor selective antagonist naltrindole 50-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement. Behav Brain Res 182: 140-144.
49. Zhang Z, Cai Y, Zou F, Bie B, Pan ZZ (2011). Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med 17: 1448-1455.
50. Zhu W, Bie B, Pan ZZ (2007). Involvement of non-NMDA glutamate receptors in central amygdala in synaptic actions of ethanol and ethanol-induced reward behavior. J Neurosci 27: 289-298.